Literature DB >> 10458283

Pathology findings with acrylic implants.

D San Millán Ruíz1, K Burkhardt, B Jean, M Muster, J B Martin, J Bouvier, J H Fasel, D A Rüfenacht, A M Kurt.   

Abstract

We report the pathological findings in cases of acrylic implants obtained by direct intratumoral injection of polymethyl-methacrylate (PMMA) and N-butyl-cyano-acrylate (NBCA). Direct intratumoral injection of acrylic implants was performed for a variety of primary and secondary bone lesions. These types of treatments have been used at our institution in the last 4 years for 40 vertebroplasty (PMMA) procedures and for nine bone lesions of other locations (PMMA, NBCA). Postmortem histology became available for 1 case of PMMA and for 5 cases with NBCA intratumoral acrylic implants. The pathological findings associated with PMMA and NBCA were evaluated and compared. PMMA exhibited a macroscopic and microscopic rim of tumor necrosis, 6 months after implantation. NBCA exhibited compressive effects on the nearby tumor tissue, however, without signs of significant necrosis outside the acrylic tumor cast. Tumor captured inside the acrylic cast showed extensive to near complete necrosis. Acrylic implants may lead to necrosis when injected directly in tumors. The necrotizing effect may extend beyond the limits of an implant in the case of PMMA. Such an extended effect of PMMA, when compared with NBCA, may be due to the variable toxicity of acrylic implants, including the different degrees of the exothermic reaction during polymerization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458283     DOI: 10.1016/s8756-3282(99)00140-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  27 in total

Review 1.  Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures.

Authors:  J M Mathis; J D Barr; S M Belkoff; M S Barr; M E Jensen; H Deramond
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Therapeutic effects of percutaneous vertebroplasty for vertebral metastases.

Authors:  Yuji Mikami; Yuji Numaguchi; Nobuo Kobayashi; Sokun Fuwa; Yoshimitsu Hoshikawa; Yukihisa Saida
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

3.  Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions.

Authors:  Salvatore Masala; Tommaso Volpi; Francesco P M Fucci; Maria Cantonetti; Massimiliano Postorino; Giovanni Simonetti
Journal:  Support Care Cancer       Date:  2010-05-27       Impact factor: 3.603

4.  A new cannula to ease cement injection during vertebroplasty.

Authors:  G Baroud; T Steffen
Journal:  Eur Spine J       Date:  2005-01-26       Impact factor: 3.134

5.  Longitudinal long-term results of surgical treatment in patients with osteochondritis dissecans of the femoral condyles.

Authors:  Juergen Bruns; Mark Rayf; Joern Steinhagen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-05       Impact factor: 4.342

Review 6.  Vertebroplasty for metastasis.

Authors:  Markus Wenger
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

7.  Grade I chondrosarcoma of bone: the Münster experience.

Authors:  Arne Streitbürger; Helmut Ahrens; Maurice Balke; Horst Buerger; Winfried Winkelmann; Georg Gosheger; Jendrik Hardes
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-15       Impact factor: 4.553

8.  Treatment of acute thoracolumbar burst fractures with kyphoplasty and short pedicle screw fixation: Transpedicular intracorporeal grafting with calcium phosphate: A prospective study.

Authors:  Panagiotis Korovessis; Thomas Repantis; Petsinis George
Journal:  Indian J Orthop       Date:  2007-10       Impact factor: 1.251

9.  Fibrous dysplasia in axis treated with vertebroplasty.

Authors:  Kadir Kotil; Emine Ozyuvaci
Journal:  J Craniovertebr Junction Spine       Date:  2010-07

10.  Subsequent fractures post-vertebral augmentation: analysis of a prospective randomized trial in osteoporotic vertebral compression fractures.

Authors:  L Gilula; M Persenaire
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.